pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3160-1 |
Genomic Coordinates | chr11: 46451805 - 46451889 |
Description | Homo sapiens miR-3160-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
pre-miRNA | hsa-mir-3160-2 |
Genomic Coordinates | chr11: 46451807 - 46451887 |
Description | Homo sapiens miR-3160-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3160-3p | ||||||||||||||||||||||||||||||
Sequence | 54| AGAGCUGAGACUAGAAAGCCCA |75 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GDE1 | ||||||||||||||||||||
Synonyms | 363E6.2, MIR16 | ||||||||||||||||||||
Description | glycerophosphodiester phosphodiesterase 1 | ||||||||||||||||||||
Transcript | NM_016641 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GDE1 | |||||||||||||||||||||
3'UTR of GDE1 (miRNA target sites are highlighted) |
>GDE1|NM_016641|3'UTR 1 ACTTTCACGGTGGGACGAAACGGGTTCAGAAACTGCCAGGGGCCTCATACAGGGATATCAAAATACCCTTTGTGCTAGCC 81 CAGGCCCTGGGGAATCAGGTGACTCACACAAATGCAATAGTTGGTCACTGCATTTTTACCTGAACCAAAGCTAAACCCGG 161 TGTTGCCACCATGCACCATGGCATGCCAGAGTTCAACACTGTTGCTCTTGAAAATCTGGGTCTGAAAAAACGCACAAGAG 241 CCCCTGCCCTGCCCTAGCTGAGGCACACAGGGAGACCCAGTGAGGATAAGCACAGATTGAATTGTACAGTTTGCAGATGC 321 AGATGTAAATGCATGGGACATGCATGATAACTCAGAGTTGACATTTTAAAACTTGCCACACTTATTTCAAATATTTGTAC 401 TCAGCTATGTTAACATGTACTGTAGACATCAAACTTGTGGCCATACTAATAAAATTATTAAAAGGAGCACTAAAGGAAAA 481 CTGTGTGCCAAGCATCATATCCTAAGGCATACGGAATTTGGGGAAGCCACCATGCAATCCAGTGAGGCTTCAGTGTACAG 561 CAACCAAAATGGTAGGGAGGTCTTGAAGCCAATGAGGGATTTATAGCATCTTGAATAGAGAGCTGCAAACCACCAGGGGG 641 CAGAGTTGCATTTTTCCAGGCTTTTTAGGAAGCTCTGCAACAGATGTGATCTGATCATAGGCAATTAGAACTGGAAGAAA 721 CTTCCAAAAATATCTAGGTTTGTCCTCATTTTACAAATGAGGAAACTAAACTCTGTGGAAGGGAAGGGGTTGCCTCAAAA 801 GTCACAGCTTAGCTGGGCACAGTGGCTCATGCCGATAATCCCAGCAATTCAGAAAGCTGAGGCAGGAGGATTACTTGAGG 881 CCAGACTGGGCAATATAGCAAGACCCCATCTCTAAAAAATTAGGCATGGTGGTGCATGCCTGTATTCCCAGCTACTCAGG 961 AGGTTGAGGTGGGAGGATCACTTGAGCCCAGAAGTTCAAGGCTGCAATGAGCCATGATTACACCACGGCACTACAACCTT 1041 GGTGGCACAGTGAGAACCTGACTCTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGATAACTAGAACTTCTAGAACATCT 1121 TGTTTACAGTTAGCCAGAAACTATACAAGTGGTTTAACATGCATTATCTTACTCAATCCATACAAAAGTCTTATGGAGGT 1201 GTTAGCACTCTTTCTACTGATGAAGAACTGAGGTACTTCATAAAACCACTTACCCAAGGTGTCTTGAGTCTGGTACAACT 1281 GGCATTCAAATCTAGGTCAGTCTGCCCCCAGAGCCACTACCCTTACCCCTCACTGAATCTGCCTTTATATTGTTGAGCCC 1361 ATGACCCCAAACTGCTCTTTCCAATTTGAACTTCCAGGGATTTTATTGTGAACTTACATAGCAACATTAAAATGAAGTTG 1441 AATTGTTTTTAATGGCAACGCCGTCTGTCTCCTCTAGCTTACCGCTTCTCACCTTTCAACCCCATCTGTGGCCTTTGTCC 1521 AGGCCCACAGCTTAGCCATGGCTTCCCTCCTGCATCCCTGCCGTGGGTTGCTGGCCTCACACTTGCAGCAGCTGGACAGT 1601 GATTTTAGAAGGCCACCAGTCCCCATAGCTATGTGACAATGAGAAGCAAACTTTTTTGTGACAGATTGTATTGGCATAGG 1681 CATGATAGATGGGGATTGGTACGTTTTGAATCAGCATTTGCAAAAAAATTGTCTTGAATTTTAAAATAAACAACAAAGAT 1761 TTGTTCATTGAGTGCAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177625. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_3
PAR-CLIP data was present in ERX177616. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_6
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000353258.3 | 3UTR | CUCACUGCAACCUCUGCCUCCUGGGUCCAAGCAAUUCUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
118 hsa-miR-3160-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT066658 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT075318 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT077083 | EIF1 | eukaryotic translation initiation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT100381 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
2 | 6 | ||||||
MIRT135259 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT184913 | ZNF268 | zinc finger protein 268 | ![]() |
![]() |
2 | 2 | ||||||
MIRT218862 | CDKN1A | cyclin dependent kinase inhibitor 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT446580 | FPR2 | formyl peptide receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448834 | FGD4 | FYVE, RhoGEF and PH domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449455 | RNF13 | ring finger protein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452284 | CARD8 | caspase recruitment domain family member 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452628 | FAM162A | family with sequence similarity 162 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT453454 | GLG1 | golgi glycoprotein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454188 | AP1S3 | adaptor related protein complex 1 sigma 3 subunit | ![]() |
![]() |
2 | 6 | ||||||
MIRT454434 | GTF2F1 | general transcription factor IIF subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454575 | NT5DC3 | 5'-nucleotidase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455555 | TRAF1 | TNF receptor associated factor 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT455841 | MPL | MPL proto-oncogene, thrombopoietin receptor | ![]() |
![]() |
2 | 6 | ||||||
MIRT455969 | BCAS4 | breast carcinoma amplified sequence 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT456805 | SIGLEC14 | sialic acid binding Ig like lectin 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457320 | DUSP19 | dual specificity phosphatase 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457366 | POFUT2 | protein O-fucosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457684 | ZNF587 | zinc finger protein 587 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458158 | LYRM4 | LYR motif containing 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT458641 | SGPP2 | sphingosine-1-phosphate phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459134 | FADS6 | fatty acid desaturase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459153 | NARF | nuclear prelamin A recognition factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT460460 | NOM1 | nucleolar protein with MIF4G domain 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT460974 | STK17B | serine/threonine kinase 17b | ![]() |
![]() |
2 | 2 | ||||||
MIRT461439 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461507 | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT462490 | GSR | glutathione-disulfide reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT462638 | PHF5A | PHD finger protein 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT463279 | ZFX | zinc finger protein, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT463360 | ZFAND4 | zinc finger AN1-type containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465777 | TMOD3 | tropomodulin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466143 | TMEM120B | transmembrane protein 120B | ![]() |
![]() |
2 | 2 | ||||||
MIRT468401 | SETD3 | SET domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468998 | RNPS1 | RNA binding protein with serine rich domain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471574 | PARD6B | par-6 family cell polarity regulator beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT472108 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472125 | NME1-NME2 | NME1-NME2 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT473020 | MRPS14 | mitochondrial ribosomal protein S14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT473083 | MORN4 | MORN repeat containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475598 | HMGB2 | high mobility group box 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT475937 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT476117 | GPR157 | G protein-coupled receptor 157 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476406 | GDE1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478003 | DNAL1 | dynein axonemal light chain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487969 | IQSEC2 | IQ motif and Sec7 domain 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489418 | TUBB2A | tubulin beta 2A class IIa | ![]() |
![]() |
2 | 2 | ||||||
MIRT491522 | IL10RA | interleukin 10 receptor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT492673 | PLEC | plectin | ![]() |
![]() |
2 | 2 | ||||||
MIRT493545 | ICOSLG | inducible T-cell costimulator ligand | ![]() |
![]() |
2 | 2 | ||||||
MIRT513085 | USP9X | ubiquitin specific peptidase 9, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT514009 | CECR2 | CECR2, histone acetyl-lysine reader | ![]() |
![]() |
2 | 4 | ||||||
MIRT516683 | ZNF860 | zinc finger protein 860 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518392 | ZNF250 | zinc finger protein 250 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522683 | LUZP1 | leucine zipper protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT524488 | CEP97 | centrosomal protein 97 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527457 | CLEC12B | C-type lectin domain family 12 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT527705 | IL17REL | interleukin 17 receptor E like | ![]() |
![]() |
2 | 2 | ||||||
MIRT531647 | C19orf52 | translocase of inner mitochondrial membrane 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532381 | UMPS | uridine monophosphate synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT532588 | MTHFD1 | methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533555 | TPM4 | tropomyosin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548371 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT550250 | PVR | poliovirus receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT552555 | ZFP36L2 | ZFP36 ring finger protein like 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554113 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554131 | SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561344 | ZBTB18 | zinc finger and BTB domain containing 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561638 | RUNX3 | runt related transcription factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566497 | PBX2P1 | PBX homeobox 2 pseudogene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570583 | OTUD7B | OTU deubiquitinase 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT572731 | MCTS1 | MCTS1, re-initiation and release factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT574041 | PEX26 | peroxisomal biogenesis factor 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575231 | Fut1 | fucosyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT606811 | BICD2 | BICD cargo adaptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621016 | CLSTN3 | calsyntenin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637852 | PDCL3 | phosducin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640477 | ZNF557 | zinc finger protein 557 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642827 | LINC00346 | long intergenic non-protein coding RNA 346 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643887 | IMP4 | IMP4, U3 small nucleolar ribonucleoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT664874 | PCNXL2 | pecanex homolog 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680528 | PRIM2 | DNA primase subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680648 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680807 | ZNF578 | zinc finger protein 578 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680921 | STX2 | syntaxin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681112 | CEP57L1 | centrosomal protein 57 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681147 | INTS7 | integrator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681966 | TFCP2 | transcription factor CP2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684316 | GTF3C4 | general transcription factor IIIC subunit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684906 | GSG2 | histone H3 associated protein kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT685499 | MED16 | mediator complex subunit 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685929 | MOCS3 | molybdenum cofactor synthesis 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686875 | SLC25A32 | solute carrier family 25 member 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688204 | FNIP1 | folliculin interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688791 | CCNB1 | cyclin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689227 | RPS19 | ribosomal protein S19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690470 | ZNF33A | zinc finger protein 33A | ![]() |
![]() |
2 | 2 | ||||||
MIRT691982 | PLCXD1 | phosphatidylinositol specific phospholipase C X domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694006 | PPIL4 | peptidylprolyl isomerase like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694529 | TRIM72 | tripartite motif containing 72 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695420 | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT695784 | HSD17B12 | hydroxysteroid 17-beta dehydrogenase 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697799 | UBXN2A | UBX domain protein 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT698275 | TMEM2 | transmembrane protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698317 | TMEM136 | transmembrane protein 136 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699971 | RREB1 | ras responsive element binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700717 | PNO1 | partner of NOB1 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT701721 | MTMR12 | myotubularin related protein 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701879 | MPLKIP | M-phase specific PLK1 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT702959 | HIF1A | hypoxia inducible factor 1 alpha subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT706178 | ZNF716 | zinc finger protein 716 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706463 | SPRED1 | sprouty related EVH1 domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718154 | TTC33 | tetratricopeptide repeat domain 33 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718711 | ANKRD18A | ankyrin repeat domain 18A | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|